Wolverine Trading, LLC Trans Medics Group, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $746,240 - $968,605	5,500 Added 32.74%	22,300 $3.5 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $188,812 - $391,612	2,600 Added 18.31%	16,800 $2.53 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $7,086 - $8,993	-100 Reduced 0.7%	14,200 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $367,400 - $810,800	10,000 Added 232.56%	14,300 $1.13 Million
Q3 2023 Nov 15, 2023	BUY	$53.47 - $96.07 $229,921 - $413,100	4,300 New	4,300 $235,000
Q3 2021 Nov 12, 2021	BUY	$25.92 - $34.51 $147,744 - $196,707	5,700 Added 38.26%	20,600 $655,000
Q2 2021 Aug 06, 2021	BUY	$21.63 - $40.07 $322,287 - $597,043	14,900 New	14,900 $490,000

396

31.7M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.82B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.